2017-2018 Influenza Vaccine Supply
AAP staff gathers information each year to respond to your concerns about flu vaccine distribution and delivery. As is the case with flu, each season is a bit different, so the information shared is specific to this season and will likely change next year. Please know that the AAP will continue to advocate on your behalf, and on the behalf of children, throughout the flu season. ACIP continued the recommendation that live attenuated influenza virus vaccine (LAIV, Flumist, MedImmune) not be used during the 2017–2018 season. More data is anticipated on this topic in October.
Influenza Vaccines for the 2017-2018 Influenza Season
Changes from last year's vaccine influenza options include:
- FluLaval Quadrivalent (GSK) is now licensed for children ≥6 months of age. It was previously licensed for those ≥3 years of age.
- ACIP now recommends use of Afluria (Seqirus) for persons ≥5 years of age, in line with the vaccine's FDA licensure.